Otsuka Gets Discovery Platform, PKU Asset In $1.3bn Jnana Acquisition

Major Japanese firm picks up US drug discovery platform company Jnana in apparent bid to strengthen discovery capabilities and build its mid-stage R&D presence in the renal area. 

Otsuka's obtains JNT-517 by the $1.1bn-worth acquisition of Janna.
Otsuka paying up to $1.3bn for US discovery platform company Jnana • Source: Shutterstock

More from Deals

More from Business